These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21819975)

  • 21. Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease.
    Clipp EC; Moore MJ
    Clin Pharmacol Ther; 1995 Aug; 58(2):228-36. PubMed ID: 7648773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
    Doddy RS; Massman PJ; Mawad M; Nance M
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
    Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
    J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum CRP levels in pre-dialysis patients.
    Razeghi E; Parkhideh S; Ahmadi F; Khashayar P
    Ren Fail; 2008; 30(2):193-8. PubMed ID: 18300120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory markers in AD and MCI patients with different biomarker profiles.
    Schuitemaker A; Dik MG; Veerhuis R; Scheltens P; Schoonenboom NS; Hack CE; Blankenstein MA; Jonker C
    Neurobiol Aging; 2009 Nov; 30(11):1885-9. PubMed ID: 18378357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels.
    Mangiafico RA; Sarnataro F; Mangiafico M; Fiore CE
    Age Ageing; 2006 Jan; 35(1):60-5. PubMed ID: 16364935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased plasma antioxidants in patients with Alzheimer's disease.
    Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient versus informant perspectives of Quality of Life in Mild Cognitive Impairment and Alzheimer's disease.
    Ready RE; Ott BR; Grace J
    Int J Geriatr Psychiatry; 2004 Mar; 19(3):256-65. PubMed ID: 15027041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
    Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
    Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary study of the relationship between thyroid status and cognitive and neuropsychiatric functioning in euthyroid patients with Alzheimer dementia.
    Stern RA; Davis JD; Rogers BL; Smith KE; Harrington CJ; Ott BR; Jackson IM; Prange AJ
    Cogn Behav Neurol; 2004 Dec; 17(4):219-23. PubMed ID: 15622018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease].
    Polidori MC; Stahl W; De Spirt S; Pientka L
    Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment.
    Xu G; Zhou Z; Zhu W; Fan X; Liu X
    J Neurol Sci; 2009 Sep; 284(1-2):77-80. PubMed ID: 19419739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein and cognitive deficits in systemic lupus erythematosus.
    Shucard JL; Gaines JJ; Ambrus J; Shucard DW
    Cogn Behav Neurol; 2007 Mar; 20(1):31-7. PubMed ID: 17356342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC; Harmon ME; Burlingame R; Du Clos TW
    J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically active Crohn's disease in the presence of a low C-reactive protein.
    Florin TH; Paterson EW; Fowler EV; Radford-Smith GL
    Scand J Gastroenterol; 2006 Mar; 41(3):306-11. PubMed ID: 16497618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inflammatory markers in Alzheimer's disease and vascular dementia].
    Androsova LV; Mikhaĭlova NM; Zozulia SA; Dupin AM; Rassadina GA; Lavrent'eva NV; Kliushnik TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):49-53. PubMed ID: 23528583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomolar aluminum induces expression of the inflammatory systemic biomarker C-reactive protein (CRP) in human brain microvessel endothelial cells (hBMECs).
    Alexandrov PN; Kruck TP; Lukiw WJ
    J Inorg Biochem; 2015 Nov; 152():210-3. PubMed ID: 26265215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased C-reactive protein levels in Alzheimer disease.
    O'Bryant SE; Waring SC; Hobson V; Hall JR; Moore CB; Bottiglieri T; Massman P; Diaz-Arrastia R
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):49-53. PubMed ID: 19933496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process.
    Song IU; Chung SW; Kim YD; Maeng LS
    Int J Med Sci; 2015; 12(8):613-7. PubMed ID: 26283879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.